A recent study published in *Nature Metabolism* provides one of the most detailed molecular maps of prolonged fasting in humans. Researchers at Queen Mary University of London tracked 12 healthy volunteers during a seven-day water-only fast using daily proteomics analysis of approximately 3,000 circulating proteins. The body switched from glucose to fat oxidation within 48–72 hours, producing an average 5.7 kg weight loss. Most lean-mass loss was restored after three days of refeeding, while fat loss was largely retained. The most pronounced systemic changes, however, emerged only after day three and involved more than one-third of measured proteins, particularly those regulating the extracellular matrix, neuronal support structures, and inflammatory pathways. These coordinated shifts suggest that clinically relevant metabolic, immune, and potential neuroprotective effects require sustained caloric restriction beyond the shorter windows used in most intermittent-fasting regimens.

For Indian clinicians, the findings reinforce both opportunity and caution. Prolonged fasting appears to modulate pathways linked to insulin sensitivity, lipid metabolism, and low-grade inflammation, offering a mechanistic basis for observed benefits in metabolic disorders. At the same time, the study recorded transient rises in platelet-activation and clotting-related proteins, underscoring risks of electrolyte imbalance, dehydration, and muscle loss. Extended fasting should therefore be considered only under medical supervision and is contraindicated in patients with diabetes, cardiovascular disease, or eating disorders. The data also support future development of fasting-mimetic therapies that could deliver similar molecular effects without requiring complete food deprivation.